Serum Periostin Levels are Significantly Higher in Patients with Primary Hyperparathyroidism and Closely Related to Osteoporosis
Experimental and Clinical Endocrinology & Diabetes · 01.09.2023 · 131 (09) · 449-455
DOI: 10.1055/a-2053-8090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.09.2023. Verfasst von Ismail Yigitdol und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Health Sciences - Adana Health Practice and Research Center, Adana, Turkey. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Osteoporosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Periostin is an emerging biomarker that plays a role in bone metabolism and may be associated with bone mineral density (BMD). This study is aimed to investigate serum periostin levels in patients with primary hyperparathyroidism (PHPT) and its correlation with BMD in these patients.
Methods
Forty patients with newly diagnosed PHPT without co-morbidities and 30 healthy controls were included. Laboratory tests for the diagnosis of PHPT and serum levels of periostin were measured for all patients. BMD was measured on lumbar spines L1 and L4 by dual-energy X-ray absorptiometry (DEXA). Serum periostin levels were detected using an enzyme-linked immunosorbent assay (ELISA).
Results
Serum periostin levels were significantly higher in patients with PHPT than in healthy controls (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Health Sciences - Adana Health Practice and Research Center, Adana, Turkey.
- Department of Emergency Medicine, University of Health Sciences - Adana Health Practice and Research Center, Adana, Turkey.
Zitieren
APA
Yigitdol, I., Gulumsek, E., Ozturk, H. A., Arici, F. N., Akbal, K., Pirinci, O., Karacay, M., Cihan, T. N., Totik, Z. G., Akyildiz, M. A., Avci, B. S., Avci, A., & Sumbul, H. E. (2023). Serum Periostin Levels are Significantly Higher in Patients with Primary Hyperparathyroidism and Closely Related to Osteoporosis. Experimental and Clinical Endocrinology & Diabetes, 131(09), 449-455. https://doi.org/10.1055/a-2053-8090
Vancouver
Yigitdol I, Gulumsek E, Ozturk HA, Arici FN, Akbal K, Pirinci O, et al. Serum Periostin Levels are Significantly Higher in Patients with Primary Hyperparathyroidism and Closely Related to Osteoporosis. Experimental and Clinical Endocrinology & Diabetes. 2023;131(09):449-455. doi:10.1055/a-2053-8090
BibTeX
@article{Yigitdol2023,
author = {Yigitdol, Ismail and Gulumsek, Erdinc and Ozturk, Huseyin Ali and Arici, Fatih Necip and Akbal, Kubilay and Pirinci, Okan and Karacay, Mert and Cihan, Tutku Naz and Totik, Zeynep Gizem and Akyildiz, Mustafa Aykut and Avci, Begum Seyda and Avci, Akkan and Sumbul, Hilmi Erdem},
title = {Serum Periostin Levels are Significantly Higher in Patients with Primary Hyperparathyroidism and Closely Related to Osteoporosis},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {09},
pages = {449--455},
doi = {10.1055/a-2053-8090}
}
EUVIMED